Cyclo(RGDyK) trifluoroacetate
CAS : 250612-42-1
Ref. 3D-AKA61242
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
Cyclo(RGDyK) trifluoroacetate
Description :
Cyclo(RGDyK) trifluoroacetate is a cilengitide that has been shown to inhibit tumor growth in xenografts. It binds to the cancer cell surface and inhibits the formation of heterodimers between integrin αvβ3 and its ligand, vitronectin. The inhibition of these heterodimer formation leads to an inhibitory effect on tumor angiogenesis. Cyclo(RGDyK) trifluoroacetate has been shown to have a high uptake in human serum, tissues, and tumors. This drug also has pharmacokinetic properties and molecular modeling studies have shown that it can be conjugated with positron-emitting isotopes for imaging. Cyclo(RGDyK) trifluoroacetate is taken up by MCP-7 cells at a higher rate than other cells due to its RGD sequence.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
847.72 g/mol
Formule :
C31H43F6N9O12
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
